Understanding Anaplastic Large Cell Lymphoma
Author Information
Author(s): Piccaluga Pier Paolo, Gazzola Anna, Mannu Claudia, Agostinelli Claudio, Bacci Francesco, Sabattini Elena, Sagramoso Carlo, Piva Roberto, Roncolato Fernando, Inghirami Giorgio, Pileri Stefano A.
Primary Institution: University of Bologna
Hypothesis
The study aims to revise the concept of anaplastic large cell lymphoma (ALCL) based on the updated WHO classification.
Conclusion
The study concludes that ALK+ and ALK− ALCL are distinct entities with different clinical features and treatment responses.
Supporting Evidence
- ALK+ tumors have a significantly better outcome than ALK− ALCL.
- Up to 90% of ALK+ ALCLs achieve complete remission with standard therapies.
- ALK− ALCL may require more aggressive treatment strategies.
Takeaway
Anaplastic large cell lymphoma is a type of cancer that can be either ALK-positive or ALK-negative, and they behave differently in terms of treatment and outcomes.
Methodology
The authors review the main pathobiological features of systemic ALCL based on their experience and recent literature.
Participant Demographics
The study notes that ALCL has a peak incidence in childhood and is more common in males.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website